Stratatech Corporation

Hazelwood, MO

UEI
WE88ZJ5AY3F9
CAGE
46WA2
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
675 James S. McDonnell Blvd, Hazelwood, MO 63042, USA
Founded
1867
Employees
1K-5K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 -$29,096,292

Contract vehicles

Contract awards

Award Agency Obligated Awarded
Phase 2 clinical trial - stratagraft - performance of a phase 2 clinical trial to evaluate safety and efficacy of an… W81XWH16C0202 Medical Command (Army) $2,730,436
DHP sibr PH II #OSD11-H10 W81XWH15C0080 Medical Command (Army) $999,957
Cell based skin subs for definitive care of burn injuries HHSO100201500027C Office of the Assistant Secretary for Preparedness and Response $75,284,563
For other functionsdevelopment of stratagraft, a living cell-based tissue with characteristics similar to human skin. HHSO100201300017C Office of the Assistant Secretary for Preparedness and Response $17,785,895
11271008 tatrc sbir phase I P W81XWH12C0063 Medical Command (Army) $1,149,924

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Award Agency Obligated Awarded
Preclinical development of epiready, a novel therapeutic to treat nonhealing diabetic foot ulcers W81XWH1610331 Medical Command (Army) $1,698,207
Biological active advanced antimicrobial human skin substitute for the treatment of combat wounds W81XWH1220110 Department of Defense $1,565,343
Stratascreensens, skin sensitizer detection in luminescent 3D human skin models R43ES022111 National Institutes of Health $199,995
Sbir phase II: an innovative full-thickness human skin model for increased throughput screening in drug discovery 1058591 National Science Foundation $499,877
Development of an antimicrobial cellular therapeutic for inhibition of biofilm FO R44AI090778 National Institutes of Health $3,458,813

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Endo Usa, Inc. UEI D739PJVW5JF9 Malvern, PA 325412 Pharmaceutical Preparation Manufacturing
Ascendis Pharma, Inc. UEI UKN2MTNJ9WM5 — 325412 Pharmaceutical Preparation Manufacturing
Acer Therapeutics Inc. UEI C6EKP8VELDC1 Boston, MA 456110 Pharmacies and Drug Retailers
Summit SD LLC UEI UDJGBMSWVZQ5 Lee's Summit, MO 424210 Drugs and Druggists' Sundries Merchant Wholesalers
U.s. Division UEI XEEKF6DJLC34 Rockville, MD 424210 Drugs and Druggists' Sundries Merchant Wholesalers

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Stratatech Corporation is a subsidiary of Mallinckrodt Plc, a global specialty pharmaceutical company that develops, manufactures, markets, and distributes branded and generic specialty pharmaceutical products and therapies. Stratatech Corporation has been registered in SAM.gov since 2005 to receive federal contract and grant awards as a foreign-owned, for-profit corporate entity.

Through federal grant awards, Stratatech Corporation has provided advanced regenerative medicine products and therapeutic tissue products. One notable sub-grant award from an unspecified agency funded the "EXPRESSGRAFT (VEGF) Manufacturing on Tissue Foundry Line" project, likely involving development or manufacturing of an experimental tissue-engineered graft product. Stratatech's grant work appears focused on innovative regenerative medicine and tissue engineering aimed at developing new therapeutic products.

Stratatech Corporation currently holds two active federal contract Indefinite Delivery Vehicle (IDV) awards from the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 12. The primary IDV is a Federal Supply Schedule contract under the Pharmaceuticals and Drugs Schedule 65 IB to provide pharmaceuticals, drugs, and hematology-related products to VA medical facilities within Network 12. This multiple-award schedule has a potential value of $850,000 and runs through March 2027. An earlier interim agreement under this same schedule provided $25,000 for similar pharmaceutical procurement within Network 12 from November 2021 to April 2022. Through these IDVs, Stratatech Corporation supplies a range of pharmaceutical treatments, medications for chronic diseases, hematology products, and other drug-based therapies to support healthcare services for veterans across VA's Network 12 region.

Quick answers

Is Stratatech Corporation registered in SAM.gov?

Yes. Stratatech Corporation's SAM.gov registration is active through June 3, 2027.

What is Stratatech Corporation's CAGE code?

Stratatech Corporation's CAGE code is 46WA2, and its Unique Entity ID (UEI) is WE88ZJ5AY3F9.

Which contract vehicles does Stratatech Corporation hold?

Stratatech Corporation holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Stratatech Corporation's most recent federal award?

Stratatech Corporation's most recent federal contract award is Phase 2 clinical trial - stratagraft - performance of a phase 2 clinical trial to evaluate safety and efficacy of an… (W81XWH16C0202), from Medical Command (Army), on September 29, 2016.

On GovTribe

See Stratatech Corporation's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe